Busulfan, cyclophosphamide and melphalan is an effective preparative regimen for children with acute myeloid leukemia given allogeneic hematopoietic stem cell transplantation in 1st complete remission

被引：0
|
作者：
Locatelli, F
Zecca, M
Pession, A
Lanino, E
Rondelli, R
Messina, C
Fagioli, F
Ripaldi, M
Andolina, M
Uderzo, C
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [31] Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
    Kunadt, Desiree
    Stoelzel, Friedrich
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7411 - 7427
  • [32] Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) Not in First Remission
    Sweet, Kendra L.
    Lancet, Jeffrey E.
    Hillgruber, Ryan
    Melody, Megan
    Llishi, Amina
    Perkins, Janelle
    Fernandez, Hugo F.
    Field, Teresa
    BLOOD, 2015, 126 (23)
  • [33] Conditioning with busulfan and fludarabine for allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukaemia: a comparison to busulfan and cyclophosphamide
    Lee, S. H.
    Cheuh, H.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S139 - S139
  • [34] Long-Term Efficacy Analysis of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia Using Melphalan Instead of Cyclophosphamide As a Myeloablative Conditioning Regimen
    Zhang, Ying
    Pang, Aiming
    Yang, Donglin
    Huang, Yong
    Wei, Jialin
    He, Yi
    Ma, Qiaoling
    Feng, Sizhou
    Han, Mingzhe
    Jiang, Erlie
    BLOOD, 2022, 140 : 12842 - 12843
  • [35] Factors influencing outcome and incidence of long-term complications in children given autologous stem cell transplantation for acute myeloid leukemia in 1st complete remission.
    Locatelli, F
    Labopin, M
    Ortega, J
    Meloni, G
    Dini, G
    Messina, C
    Yaniv, I
    Fagioli, F
    Castel, V
    Shaw, P
    Ferrant, A
    Pession, A
    Sociè, G
    Frassoni, F
    BLOOD, 2001, 98 (11) : 858A - 859A
  • [36] MELPHALAN VERSUS CYCLOPHOSPHAMIDE WITH TOTAL-BODY IRRADIATION AS CONDITIONING FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN 1ST REMISSION ACUTE MYELOID-LEUKEMIA
    MEHTA, J
    POWLES, R
    TRELEAVEN, J
    SINGHAL, S
    HORTON, C
    TAIT, D
    MILAN, S
    MELLER, S
    PINKERTON, CR
    CHANG, J
    HAMBLIN, M
    ODRISCOLL, A
    ZOMAS, A
    CATOVSKY, D
    BLOOD, 1994, 84 (10) : A714 - A714
  • [37] Adding busulfan with cyclophosphamide/total body irradiation as preparative regimen for allogeneic stem cell transplantation improve survival in advanced myeloid leukaemia
    Asai, O
    Usui, N
    Yano, S
    Dobashi, N
    Ichiba, T
    Saito, T
    Minami, J
    Otsubo, H
    Hoshi, Y
    Kobayashi, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S221 - S221
  • [38] Autologous hematopoietic stem cell transplantation (AHSCT) as consolidation therapy for childhood acute myelogenous leukemia in 1st complete remission
    Biagi, E
    Rovelli, A
    De Lorenzo, P
    Uderzo, C
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2001, 18 (05) : 359 - 362
  • [39] Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission
    Moya, Tommy Alfaro
    Mattsson, Jonas
    Remberger, Mats
    Lipton, Jeffrey H.
    Kim, Dennis D.
    Viswabandya, Auro
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun D.
    Gerbitz, Armin
    Pasic, Ivan
    Novitzky-Basso, Igor
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (04) : 553 - 561
  • [40] Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective
    Masamitsu Yanada
    International Journal of Hematology, 2015, 101 : 243 - 254
12345